Table 3 Baseline Patient-Reported Outcomes by Study Group
Score Type | Intervention Group | Usual Care | P value |
|---|---|---|---|
European Organisation for the Research and Treatment of Cancer (EORTC) Core Quality of life Questionnaire | |||
Overall and Functioning Domains | |||
QLQ summary score | 84.53 (12.45) | 83.89 (11.15) | 0.87 |
Global health status (SE) | 70.42 (21.88) | 77.08 (18.90) | 0.31 |
Physical functioning | 83.00 (16.96) | 82.81 (14.46) | 0.97 |
Role functioning | 79.17 (25.86) | 91.67 (13.79) | 0.07 |
Emotional functioning | 83.33 (15.53) | 85.00 (15.67) | 0.74 |
Cognitive functioning | 91.67 (13.79) | 85.83 (17.33) | 0.25 |
Social functioning | 81.67 (21.56) | 84.17 (15.74) | 0.68 |
Symptom Domains | |||
Fatigue | 23.33 (19.04) | 25.56 (20.10) | 0.72 |
Nausea and vomiting | 7.50 (13.76) | 3.33 (10.26) | 0.28 |
Pain | 12.50 (19.40) | 13.33 (26.27) | 0.91 |
Dyspnea | 28.33 (27.09) | 20.00 (16.75) | 0.25 |
Insomnia | 18.33 (25.31) | 25.00 (23.88) | 0.4 |
Appetite loss | 13.33 (22.69) | 11.67 (22.36) | 0.82 |
Constipation | 6.67 (13.68) | 30.00 (32.26) | 0.006 |
Diarrhoea | 10.00 (21.90) | 11.67 (19.57) | 0.8 |
Financial Difficulties | 18.33 (29.57) | 16.67 (22.94) | 0.84 |
MMRC Dyspnea Scale | 1.00 (1.05) | 1.10 (0.85) | 0.75 |
PHQ-9 Total Score (omits Q10) | 4.00 (4.10) | 3.26 (2.73) | 0.52 |